Equity, barriers and cancer disparities: study of the Spanish Society of Medical Oncology on the access to oncologic drugs in the Spanish Regions

• J. Salvador ^[12] ; J. A. Urtasun ^[13] ; F. J. B. Duart ^[1] ; R. García-Campelo ^[2] ; R. G. Carbonero ^[3] ; P. Lianes ^[4] ; A. Llombart ^[14] ; D. I. Casado ^[5] ; J. M. Piera ^[6] ; M. M. Mateu ^[15] ; J. Puente ^[7] ; F. Rivera ^[8] ; C. A. Rodríguez ^[16] ; J. A. Virizuela ^[9] ; M. Martín ^[10] ; P. Garrido ^[11]
  1. [1] Complexo Hospitalario Universitario de Santiago

     Complexo Hospitalario Universitario de Santiago

     Santiago de Compostela, España

     
  2. [2] Complexo Hospitalario Universitario da Coruña

     Complexo Hospitalario Universitario da Coruña

     A Coruña, España

     
  3. [3] Hospital Universitario Virgen del Rocío

     Hospital Universitario Virgen del Rocío

     Sevilla, España

     
  4. [4] Hospital de Mataró

     Hospital de Mataró

     Barcelona, España

     
  5. [5] Hospital Clínico Universitario Lozano Blesa

     Hospital Clínico Universitario Lozano Blesa

     Zaragoza, España

     
  6. [6] Hospital Universitario de Donostia

     Hospital Universitario de Donostia

     San Sebastián, España

     
  7. [7] Hospital Clínico San Carlos de Madrid

     Hospital Clínico San Carlos de Madrid

     Madrid, España

     
  8. [8] Hospital Universitario Marqués de Valdecilla

     Hospital Universitario Marqués de Valdecilla

     Santander, España

     
  9. [9] Hospital Universitario Virgen Macarena

     Hospital Universitario Virgen Macarena

     Sevilla, España

     
  10. [10] Hospital General Universitario Gregorio Marañón

      Hospital General Universitario Gregorio Marañón

      Madrid, España

      
  11. [11] Hospital Ramón y Cajal

      Hospital Ramón y Cajal

      Madrid, España

      
  12. [12] Hospital Universitario Nuestra Señora de Valme, España
  13. [13] Hospital Universitario y Politécnico la Fe, España
  14. [14] Hospital Universitàri Arnau de Vilanova, España
  15. [15] Hospital Clinic i Provincial, Barcelona, España
  16. [16] Hospital Clínico Universitario, Salamanca, España

  Mostrar afiliaciones +
• Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 19, Nº. 3 (March 2017), 2017, págs. 341-356
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Purpose The Spanish Society of Medical Oncology (SEOM) has conducted a study on the access to oncologic drugs across the 17 Spanish Regions with the aim of identifying potential heterogeneities and making proposals for eliminating the barriers identified at the different levels.

    Methods An Expert Panel made up of medical oncologists designed a survey on certain indications approved for 11 drugs in the approach of breast cancer, melanoma, lung cancer, prostate cancer and support treatment. This survey was sent to 144 National Health System (NHS) hospitals.

    Results 77 hospitals answered the survey. The information modules analysed were: scope of the Commission that establishes binding decisions related to drug access; conditions, stages and periods of drug application, approval and administration processes; barriers to accessing drugs.

    Conclusions The study shows variability in drug access. The SEOM makes proposals addressed to reducing the differences identified and homogenizing drug access conditions.